Company profile for PYC Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

PYC Therapeutics is a drug-development company offering a new generation of RNA therapeutics to meet unmet need in disease. We have world-leading RNA targeted therapeutics design capabilities which are supported by our revolutionary delivery technology based on Cell Penetrating Peptides (CPPs) to overcome the ‘delivery challenge’ in genomic therapies. Our differentiated drug delivery capability and RNA drug design expert...
PYC Therapeutics is a drug-development company offering a new generation of RNA therapeutics to meet unmet need in disease. We have world-leading RNA targeted therapeutics design capabilities which are supported by our revolutionary delivery technology based on Cell Penetrating Peptides (CPPs) to overcome the ‘delivery challenge’ in genomic therapies. Our differentiated drug delivery capability and RNA drug design experts means we have the skills and means to discover and develop RNA-targeted therapeutics in a truly innovative way.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
6 Verdun Street, Nedlands, Western Australia 6009
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/us-fda-designates-pycs-lead-as-a-fast-track-development-program-301898803.html

PR NEWSWIRE
11 Aug 2023

https://www.prnewswire.com/news-releases/pyc-therapeutics-announces-comprehensive-preclinical-results-demonstrating-vp-002-programs-potential-as-the-first-disease-modifying-therapy-for-autosomal-dominant-optic-atrophy-301321428.html

PRNEWSWIRE
29 Jun 2021

https://www.biospace.com/article/releases/pyc-therapeutics-announces-two-poster-presentations-at-association-for-research-in-vision-and-opthalmology-arvo-2021-annual-meeting/#:~:text=NEW%20YORK%20and%20PERTH%2C%20Australia,two%20poster%20presentations%20at%20the

BIOSPACE
04 May 2021

https://www.biospace.com/article/releases/pyc-therapeutics-highlights-continued-progress-of-ocular-and-cns-pipeline-programs-and-u-s-expansion-in-first-quarter-update/

BIOSPACE
30 Apr 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty